Steven B. Kanner

7.3k total citations
87 papers, 4.7k citations indexed

About

Steven B. Kanner is a scholar working on Immunology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Steven B. Kanner has authored 87 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 39 papers in Molecular Biology and 25 papers in Immunology and Allergy. Recurrent topics in Steven B. Kanner's work include Cell Adhesion Molecules Research (24 papers), T-cell and B-cell Immunology (22 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Steven B. Kanner is often cited by papers focused on Cell Adhesion Molecules Research (24 papers), T-cell and B-cell Immunology (22 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Steven B. Kanner collaborates with scholars based in United States, Germany and Denmark. Steven B. Kanner's co-authors include Alejandro Aruffo, J. Thomas Parsons, Albert B. Reynolds, J A Ledbetter, Jeffrey A. Ledbetter, Juan J. Pérez‐Villar, A B Reynolds, Hao Wu, Gary L. Schieven and Gena S. Whitney and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Steven B. Kanner

85 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven B. Kanner United States	37	2.2k	1.7k	1.1k	931	668	87	4.7k
François Le Naour France	32	2.5k 1.1×	1.2k 0.7×	1.6k 1.4×	940 1.0×	487 0.7×	64	5.2k
Waldemar Kolanus Germany	40	3.1k 1.4×	2.3k 1.3×	1.6k 1.4×	1.2k 1.3×	754 1.1×	87	6.1k
Stephan M. Feller United Kingdom	39	2.9k 1.3×	836 0.5×	371 0.3×	822 0.9×	837 1.3×	104	4.5k
Larry R. Rohrschneider United States	51	4.3k 2.0×	2.0k 1.2×	955 0.9×	997 1.1×	1.4k 2.1×	100	6.9k
Gerald Gish Canada	42	5.4k 2.4×	1.2k 0.7×	928 0.8×	1.5k 1.6×	1.4k 2.1×	77	7.8k
Judith P. Johnson Germany	31	1.8k 0.8×	1.3k 0.7×	750 0.7×	462 0.5×	1.0k 1.6×	67	3.6k
Tomohiko Fukuda Japan	36	2.3k 1.0×	1.1k 0.6×	744 0.7×	615 0.7×	469 0.7×	87	3.2k
Wallace Y. Langdon Australia	52	5.9k 2.7×	2.7k 1.6×	704 0.6×	1.3k 1.4×	2.4k 3.7×	122	9.2k
Marcel Deckert France	43	2.6k 1.2×	1.9k 1.1×	670 0.6×	550 0.6×	1.2k 1.8×	95	4.9k
Abraham Kupfer United States	25	1.4k 0.6×	2.8k 1.6×	490 0.4×	522 0.6×	581 0.9×	44	4.5k

Countries citing papers authored by Steven B. Kanner

Since Specialization

Citations

This map shows the geographic impact of Steven B. Kanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven B. Kanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven B. Kanner more than expected).

Fields of papers citing papers by Steven B. Kanner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven B. Kanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven B. Kanner. The network helps show where Steven B. Kanner may publish in the future.

Co-authorship network of co-authors of Steven B. Kanner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven B. Kanner. A scholar is included among the top collaborators of Steven B. Kanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven B. Kanner. Steven B. Kanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daver, Naval, Abhishek Maiti, David A. Sallman, et al.. (2024). A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify).. Journal of Clinical Oncology. 42(16_suppl). TPS6586–TPS6586. 5 indexed citations

Wooddell, Christine I., Keith Blomenkamp, Ryan M. Peterson, et al.. (2020). Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease. JCI Insight. 5(12). 40 indexed citations

Wong, So C., Weijun Cheng, Holly Hamilton, et al.. (2017). HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(1). 140–149. 27 indexed citations

Wooddell, Christine I., Man‐Fung Yuen, Henry Lik‐Yuen Chan, et al.. (2017). RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg. Science Translational Medicine. 9(409). 342 indexed citations

Melquist, Stacey, Darren H. Wakefield, Holly Hamilton, et al.. (2016). Abstract 17167: Targeting Apolipoprotein(a) With a Novel RNAi Delivery Platform as a Prophylactic Treatment to Reduce Risk of Cardiovascular Events in Individuals With Elevated Lipoprotein (a). Circulation. 7 indexed citations

Parnell, K. Mark, Jason M. Foulks, Rebecca N. Nix, et al.. (2013). Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth. Molecular Cancer Therapeutics. 12(8). 1453–1460. 55 indexed citations

Foulks, Jason M., Bai Luo, K. Mark Parnell, et al.. (2013). Synthesis and structure–activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(14). 4072–4075. 14 indexed citations

Xu, Yong, Xiaohui Liu, Michael A. Saunders, et al.. (2013). Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2). Bioorganic & Medicinal Chemistry Letters. 24(2). 515–519. 43 indexed citations

Ho, Koc-Kan, K. Mark Parnell, Yi Yuan, et al.. (2012). Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(2). 569–573. 23 indexed citations

10.

Ng, Tony, Irene Collins, Steven B. Kanner, et al.. (1999). Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus. Lupus. 8(1). 39–51. 5 indexed citations

11.

Scholler, John & Steven B. Kanner. (1997). The Human p167 Gene Encodes a Unique Structural Protein That Contains Centrosomin A Homology and Associates with a Multicomponent Complex. DNA and Cell Biology. 16(4). 515–531. 16 indexed citations

12.

Zhu, Qili, Chiaki Watanabe, Ting Liu, et al.. (1997). Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype. Blood. 90(7). 2680–2689. 185 indexed citations

13.

Kanner, Steven B.. (1996). Focal Adhesion Kinase-Related fakB Is Regulated by the Integrin LFA-1and Interacts with the SH3 Domain of Phospholipase Cγ1. Cellular Immunology. 171(1). 164–169. 17 indexed citations

14.

Grossmann, Angelika, Peter S. Rabinovitch, Terrance J. Kavanagh, et al.. (1995). Activation of Murine T-cells via Phospholipase-C l-Associated Protein Tyrosine Phosphorylation Is Reduced With Aging. The Journals of Gerontology Series A. 50A(4). B205–B212. 29 indexed citations

15.

Parsons, Marilyn, Jeffrey A. Ledbetter, Gary L. Schieven, André E. Nel, & Steven B. Kanner. (1994). Developmental regulation of pp44/46, tyrosine-phosphorylated proteins associated with tyrosine/serine kinase activity in Trypanosoma brucei. Molecular and Biochemical Parasitology. 63(1). 69–78. 39 indexed citations

16.

Ledbetter, Jeffrey A., Julie P. Deans, Alejandro Aruffo, et al.. (1993). CD4, CD8 and the role of CD45 in T-cell activation. Current Opinion in Immunology. 5(3). 334–340. 42 indexed citations

17.

Whitney, Gena S., P Y Chan, James Blake, et al.. (1993). Human T and B Lymphocytes Express a Structurally Conserved Focal Adhesion Kinase, pp125 ^FAK. DNA and Cell Biology. 12(9). 823–830. 82 indexed citations

18.

Bouton, Amy H., Steven B. Kanner, Richard Vines, & J. Thomas Parsons. (1991). Tyrosine phosphorylation of three cellular proteins correlates with transformation of rat 1 cells by pp60^src. Molecular Carcinogenesis. 4(2). 145–152. 4 indexed citations

19.

Reynolds, Albert B., Steven B. Kanner, Hwa‐Chain Robert Wang, & J. Thomas Parsons. (1989). Stable Association of Activated pp60 ^src with Two Tyrosine-Phosphorylated Cellular Proteins. Molecular and Cellular Biology. 9(9). 3951–3958. 159 indexed citations

20.

Kanner, Steven B., Albert B. Reynolds, & J. Thomas Parsons. (1989). Immunoaffinity purification of tyrosine-phosphorylated cellular proteins. Journal of Immunological Methods. 120(1). 115–124. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact